TransCure bioServices
TransCure bioServices is a preclinical contract research organization (CRO) that provides specialized humanized mouse models for drug discovery and development. The company offers CD34+ human immune system, humanized liver, and double-humanized models to evaluate the efficacy and toxicity of lead candidates in oncology, inflammatory diseases, and infectious diseases like HIV and HBV. Their services target pharmaceutical and biotechnology researchers requiring predictive in vivo studies for immunotherapy and personalized medicine.
Funding summary
- Total raised
- €2.5M
- Funding rounds
- 1
Investors in TransCure bioServices
Investors on record for TransCure bioServices. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like TransCure bioServices?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors